Payment overview · 2025
General Payments
$135.36
8 reported records · 7 companies
Healthcare provider profile · identity verified
Brent Charles Nimeth, MD
Allopathic & Osteopathic Physicians|Family Medicine · MOUNT VERNON, OH · NPI 1912935545
Verified facts
What the public records show
CMS Open Payments records show Brent Charles Nimeth, MD received $135.36 in general payments during 2025 across 8 reported records.
Dexcom, Inc. accounted for 24.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Jardiance.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Synthroid by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Jardiance by this doctor in 2024.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 213 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 213 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $33.77 | 24.9% | 2 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $20.06 | 14.8% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $19.44 | 14.4% | 1 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $16.35 | 12.1% | 1 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $15.58 | 11.5% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $15.47 | 11.4% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $14.69 | 10.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $135.36 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $33.77 | 2 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.06 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $19.44 | 1 | 2025 |
Source payment records
|
|||||
| CAMZYOS Normalized: camzyos |
Drug | E.R. Squibb & Sons, L.L.C. | $16.35 | 1 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $15.58 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $15.47 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $15.47 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $14.69 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $14.69 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 213 | exact normalized | Medicare Part D |
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 72 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
72 | 17 |
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
213 | 54 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
213 | 54 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 815 | 173 |
| Atorvastatin Calcium | Atorvastatin Calcium | 692 | 197 |
| Lisinopril | Lisinopril | 665 | 169 |
| Hydrochlorothiazide | Hydrochlorothiazide | 623 | 161 |
| Omeprazole | Omeprazole | 571 | 129 |
| Gabapentin | Gabapentin | 455 | 96 |
| Amlodipine Besylate | Amlodipine Besylate | 454 | 115 |
| Metformin Hcl | Metformin Hcl | 440 | 110 |
| Losartan Potassium | Losartan Potassium | 426 | 117 |
| Metoprolol Succinate | Metoprolol Succinate | 415 | 109 |
| Furosemide | Furosemide | 412 | 110 |
| Simvastatin | Simvastatin | 281 | 63 |
| Potassium Chloride | Potassium Chloride | 276 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 230 | 56 |
| Pioglitazone Hcl | Pioglitazone Hcl | 223 | 51 |
| Clopidogrel | Clopidogrel Bisulfate | 222 | 61 |
| Duloxetine Hcl | Duloxetine Hcl | 220 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 220 | 56 |
| Meloxicam | Meloxicam | 216 | 47 |
| Eliquis | Apixaban | 213 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 210 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 205 | 48 |
| Alprazolam | Alprazolam | 195 | 54 |
| Sertraline Hcl | Sertraline Hcl | 195 | 60 |
| Pravastatin Sodium | Pravastatin Sodium | 193 | 41 |
| Glimepiride | Glimepiride | 178 | 48 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 177 | 54 |
| Allopurinol | Allopurinol | 173 | 46 |
| Citalopram Hbr | Citalopram Hydrobromide | 170 | 47 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 169 | 44 |
| Montelukast Sodium | Montelukast Sodium | 166 | 41 |
| Trazodone Hcl | Trazodone Hcl | 160 | 42 |
| Azithromycin | Azithromycin | 158 | 114 |
| Prednisone | Prednisone | 157 | 77 |
| Temazepam | Temazepam | 148 | 28 |
| Tramadol Hcl | Tramadol Hcl | 145 | 37 |
| Donepezil Hcl | Donepezil Hcl | 136 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 135 | 55 |
| Carvedilol | Carvedilol | 121 | 35 |
| Buspirone Hcl | Buspirone Hcl | 118 | 32 |
| Famotidine | Famotidine | 117 | 29 |
| Cephalexin | Cephalexin | 113 | 92 |
| Fluoxetine Hcl | Fluoxetine Hcl | 112 | 27 |
| Lorazepam | Lorazepam | 109 | 16 |
| Warfarin Sodium | Warfarin Sodium | 108 | 24 |
| Lamotrigine | Lamotrigine | 107 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 99 | 23 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 98 | 42 |
| Oxybutynin Chloride | Oxybutynin Chloride | 95 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 90 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 85 | 24 |
| Memantine Hcl | Memantine Hcl | 84 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 29 |
| Paroxetine Hcl | Paroxetine Hcl | 80 | 21 |
| Nabumetone | Nabumetone | 79 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | 19 |
| Jardiance | Empagliflozin | 72 | 17 |
| Finasteride | Finasteride | 70 | 17 |
| Atenolol | Atenolol | 69 | 21 |
| Spironolactone | Spironolactone | 68 | 19 |
| Pregabalin | Pregabalin | 67 | 20 |
| Ibuprofen | Ibuprofen | 66 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 63 | 16 |
| Glipizide | Glipizide | 61 | 11 |
| Lovastatin | Lovastatin | 61 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 61 | 44 |
| Glipizide Er | Glipizide | 56 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 56 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 55 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 29 |
| Amoxicillin | Amoxicillin | 53 | 27 |
| Clonidine Hcl | Clonidine Hcl | 49 | 14 |
| Enalapril Maleate | Enalapril Maleate | 49 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 15 |
| Ezetimibe | Ezetimibe | 48 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 48 | 15 |
| Risperidone | Risperidone | 47 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 46 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 46 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 45 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | 12 |
| Ondansetron Odt | Ondansetron | 41 | 18 |
| Baclofen | Baclofen | 40 | 12 |
| Bupropion Xl | Bupropion Hcl | 40 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 40 | suppressed |
| Clonazepam | Clonazepam | 39 | suppressed |
| Estradiol | Estradiol | 38 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 38 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 37 | suppressed |
| Celecoxib | Celecoxib | 36 | suppressed |
| Levetiracetam | Levetiracetam | 36 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | 11 |
| Nitroglycerin | Nitroglycerin | 36 | 25 |
| Carbamazepine | Carbamazepine | 35 | suppressed |
| Naproxen | Naproxen | 35 | suppressed |
| Xarelto | Rivaroxaban | 35 | 11 |
| Acyclovir | Acyclovir | 34 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 34 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 33 | suppressed |
| Gemfibrozil | Gemfibrozil | 32 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 32 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 32 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 32 | 19 |
| Topiramate | Topiramate | 32 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 31 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Fluconazole | Fluconazole | 30 | 23 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 29 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 28 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 26 | suppressed |
| Vascepa | Icosapent Ethyl | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 24 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 24 | suppressed |
| Methotrexate | Methotrexate Sodium | 24 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 19 |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Cholestyramine Light | Cholestyramine | 22 | 12 |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Nyamyc | Nystatin | 22 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 22 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Clotrimazole | Clotrimazole | 20 | 11 |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Jantoven | Warfarin Sodium | 15 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 11 |
| Valsartan | Valsartan | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | 12 |
| Tri-Lo-Marzia | Norgestimate-Ethinyl Estradiol | 12 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 11 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $135.36 · 8 records | Dexcom, Inc. | CAMZYOS, Dexcom G6 Transmitter, ELIQUIS, JARDIANCE, Korlym, NURTEC ODT, QULIPTA, UBRELVY, VOQUEZNA | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error